CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating

Neutral
AI Analysis

Summary

Mizuho adjusted its price target on Corbus Pharmaceuticals down by $1 to $33, maintaining an Outperform rating on the stock.

Importance:2/10
Sentiment:
0.00
price_targetanalyst_note
Related Companies

Read the original article

Published by yahoo_finance on August 13, 2026 9:22 AM

Read Original